Evolus, Inc. (EOLS) Insider Trading Disclosures
Evolus, Inc. (EOLS) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: EOLS
CIK: 1570562
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerMark Montoya
Audit LocationIrvine, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-09-04 | 2026-09-02 | FORM 4 | 0001700836-26-000003 | View SEC Doc Filr Page |
| 144 | 2026-09-02 | — | 144 Filing | 0001950047-26-009034 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-31 | — | SCHEDULE 13G Filing | 0001213900-26-095761 | View SEC Doc Filr Page |
| 10-Q | 2026-08-05 | 2026-06-30 | 10-Q | 0001628280-26-053468 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-08-05 | 8-K | 0001628280-26-053384 | View SEC Doc Filr Page |
| 8-K | 2026-08-04 | 2026-08-03 | 8-K | 0001570562-26-000083 | View SEC Doc Filr Page |
| 8-K | 2026-07-08 | 2026-07-07 | 8-K | 0001570562-26-000079 | View SEC Doc Filr Page |
| EFFECT | 2026-06-12 | — | EFFECT Filing | 9999999995-26-001986 | View SEC Doc Filr Page |
| 8-K | 2026-06-12 | 2026-06-11 | 8-K | 0001570562-26-000076 | View SEC Doc Filr Page |
| CORRESP | 2026-06-10 | — | CORRESP Filing | 0001570562-26-000074 | View SEC Doc Filr Page |
| UPLOAD | 2026-06-10 | — | UPLOAD Filing | 0000000000-26-005838 | View SEC Doc Filr Page |
| S-3 | 2026-06-05 | — | S-3 | 0001570562-26-000071 | View SEC Doc Filr Page |
| 10-Q | 2026-05-04 | 2026-03-31 | 10-Q | 0001570562-26-000066 | View SEC Doc Filr Page |
| 8-K | 2026-05-04 | 2026-05-04 | 8-K | 0001570562-26-000064 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-29 | — | DEFA14A | 0001570562-26-000060 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-29 | 2026-06-11 | DEF 14A | 0001570562-26-000059 | View SEC Doc Filr Page |
| ARS | 2026-04-29 | 2025-12-31 | ARS | 0001570562-26-000057 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-03-26 | — | SCHEDULE 13G/A Filing | 0000102909-26-000415 | View SEC Doc Filr Page |
| 4 | 2026-03-20 | 2026-03-20 | FORM 4 | 0001570562-26-000050 | View SEC Doc Filr Page |
| 4 | 2026-03-20 | 2026-03-20 | FORM 4 | 0001570562-26-000049 | View SEC Doc Filr Page |
| 4 | 2026-03-18 | 2026-03-16 | FORM 4 | 0001570562-26-000046 | View SEC Doc Filr Page |
| 4 | 2026-03-18 | 2026-03-16 | FORM 4 | 0001570562-26-000045 | View SEC Doc Filr Page |
| 8-K | 2026-03-13 | 2026-03-13 | 8-K | 0001570562-26-000043 | View SEC Doc Filr Page |
| S-8 | 2026-03-03 | — | S-8 | 0001570562-26-000039 | View SEC Doc Filr Page |
| 10-K | 2026-03-03 | 2025-12-31 | 10-K | 0001628280-26-014001 | View SEC Doc Filr Page |